Hetero Biopharma Limited - pharma in Balanagar, Telangana, India. FY 2026 financials and compliance.
CIN U24290TG2016PLC111946 Incorporated 14 September 2016 ROC Hyderabad HQ Balanagar, Telangana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2024
₹387.48 Cr
▲ 13.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹166 Cr
Registered with MCA
Paid-up capital
₹45.05 Cr
Issued & subscribed
Open charges
₹252.15 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
486
Latest available

About Hetero Biopharma Limited

Data last updated: 17 December 2025

Hetero Biopharma Limited is a public limited company based in Balanagar, Telangana, India, a subsidiary of Hetero Labs Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 14 September 2016, the company has been in operation for over 10 years.

Registered with ROC Hyderabad under CIN U24290TG2016PLC111946.

Capital: an authorised share capital of ₹166 Cr and a paid-up capital of ₹45.05 Cr. It is led by directors including Bandi Vamsikrishna and Govindaraju Bhavani.

Last AGM: 28 August 2025. Financial statements filed for year ended 31 March 2025. Office: Balanagar, Telangana.

As per the financials filed for FY 2024, the company reported a revenue of ₹387.48 Cr, a growth of 13% compared to the previous year.

The company has a workforce of approximately 486 employees as per the latest available data. It operates as a subsidiary of Hetero Labs Limited. Its group structure includes 1 subsidiary.

The company is associated with 2 brands - Hetero Biopharma, Hetero. As per MCA filings, the company has open charges of ₹252.15 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hetero.com.

Company Details of Hetero Biopharma Limited
CIN U24290TG2016PLC111946
Registration Number 111946
Incorporation Date 14 September 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 August 2025
Date of Balance Sheet 31 March 2025
Parent Company Hetero Labs Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    #7 – 2 – A2 Industrial Estate, Sanath Nagar, Balanagar, Telangana, India – 500018
  • Industry
    Pharma, Drug Formulation & Development
Company report
Hetero Biopharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Hetero Biopharma Limited report

Financials, compliance, directors, charges, ownership and filings for Hetero Biopharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Hetero Biopharma Limited

Hetero Biopharma Limited operates two associated brands: Hetero Biopharma and Hetero. These brands represent Hetero Biopharma Limited's diversified market presence and brand portfolio.

Brand Description Website
Development and manufacturing of biosimilars and biopharmaceuticals are conducted by Hetero Biopharma in the healthcare sector. heterobiopharma.com
Hetero is recognized as a leading global pharmaceutical company based in India. hetero.com

Competitors & Alternatives of Hetero Biopharma Limited

Brands and companies operating in the same space as Hetero Biopharma Limited include Merck, Roivant Sciences, AbbVie and 7 more.

Competitor Description Location Founded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide. Kenilworth, United Kingdom, United Kingdom 1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. New York, United States, United States 2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie. Chicago, United States, United States 2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields. United States 1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others Foster City, United States, United States 1987
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized. Silver Spring, United States, United States 1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases. Basel, Switzerland, Switzerland 1896
Ascendis Pharma Ascendis Pharma Long-acting prodrug therapies are developed for endocrine and rare diseases. Hellerup, Denmark, Denmark 2007
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed. Planegg, Germany, Germany 1992
Vertex Pharmaceuticals Vertex Pharmaceuticals Developer of drugs for the treatment of multiple disorders United States 1989

Business Activity of Hetero Biopharma Limited

Hetero Biopharma Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Hetero Biopharma Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Hetero Biopharma Limited

Hetero Biopharma Limited is audited by M V NARAYANA REDDY & CO. for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
M V NARAYANA REDDY & CO. Locked Locked Locked
Premium access

Complete auditor history for Hetero Biopharma Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Hetero Biopharma Limited

Hetero Biopharma Limited is currently managed by 4 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Bandi Vamsikrishna Director 25 Mar 2021 5 Years 4 Months Current
Govindaraju Bhavani Director 26 Aug 2022 3 Years 11 Months Current
Parthasaradhi Reddy Bandi Director 14 Sep 2016 9 Years 11 Months Current
Bhaskarreddy Pabbatireddy Additional Director 26 Sep 2025 0 Years 10 Months Current

Financials of Hetero Biopharma Limited FY 2025 filings available

Hetero Biopharma Limited reported revenue of ₹387.48 Cr (up 13.00% YoY) for FY 2024.

Revenue · FY 2024
₹387.48 Cr ▲ 13.00%
Premium access

Ten-year financial statements for Hetero Biopharma Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Hetero Biopharma Limited

Premium access

Shareholding and ownership data for Hetero Biopharma Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Group Structure of Hetero Biopharma Limited

Hetero Biopharma Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Hetero Biopharma Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Hetero Plasma Sciences Private Limited U46497TS2023PTC175917 Locked

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Hetero Biopharma Limited

Open charges
₹252.15 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Sbicap Trustee Company Limited₹158.00 Cr
Others₹94.15 Cr
Latest charge details
DateLenderAmountStatus
27 Mar 2025 Sbicap Trustee Company Limited ₹75 Cr Open
27 Mar 2025 Sbicap Trustee Company Limited ₹83 Cr Open
14 Feb 2024 Others ₹25 Lakh Open
20 Feb 2023 Others ₹20 Lakh Open
07 Jun 2022 Others ₹97.93 Lakh Open

Total charge records: 6 View all charges

Employees and EPFO Compliance at Hetero Biopharma Limited

Hetero Biopharma Limited has a workforce of 486 employees as of Feb 25, 2025.

Employee count
486
Active EPFO establishments
1
Employee growth
-7.6%
Premium access

Employee and EPFO history for Hetero Biopharma Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Hetero Biopharma Limited

Premium access

GST registrations and filing compliance for Hetero Biopharma Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Hetero Biopharma Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Hetero Biopharma Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Hetero Biopharma Limited

Premium access

MSME payment history for Hetero Biopharma Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Hetero Biopharma Limited

Premium access

Corporate group structure for Hetero Biopharma Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Hetero Biopharma Limited

Premium access

MCA filings and documents for Hetero Biopharma Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Hetero Biopharma Limited

Directors
26 Sep 2025
Bhaskarreddy Pabbatireddy was appointed as a Additional Director on 26 Sep 2025 & has been associated with this company since 10 months 20 days.
Activity
28 Aug 2025
Hetero Biopharma Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records.
Activity
31 Mar 2025
Hetero Biopharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
27 Mar 2025
A charge with Sbicap Trustee Company Limited amounted to Rs. 75.00 Cr with Charge ID 101078891 was registered on 27 Mar 2025.
Charges
27 Mar 2025
A charge with Sbicap Trustee Company Limited amounted to Rs. 83.00 Cr with Charge ID 101077053 was registered on 27 Mar 2025.
Charges
17 Dec 2024
A charge with Others of Rs. 92.72 Cr registered on 14 Sep 2021 with Charge ID 100482619 was modified on 17 Dec 2024.

Recent News on Hetero Biopharma Limited

Frequently Asked Questions about Hetero Biopharma Limited

Hetero Biopharma Limited is an active public limited company in the pharma sector based in Balanagar, Telangana, India. It was incorporated on 14 September 2016 (10+ years old) and is registered under CIN U24290TG2016PLC111946. The company has 486 employees.

Hetero Biopharma Limited reported revenue of ₹387.48 Cr for FY 2024 (up 13.00% YoY).

The current directors of Hetero Biopharma Limited are:

The primary industry of Hetero Biopharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Hetero Biopharma Limited can be reached at the registered office: #7 – 2 – A2 Industrial Estate, Sanath Nagar, Balanagar, Telangana, India – 500018, or through the website hetero.com.

The authorised capital is ₹166 Cr, and the paid-up capital is ₹45.05 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available